Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Hampel

Showing results (211-220 of 411) with videos related to

Pageof 42
Sort By:
Brain : a Journal of Neurology|July 15, 2005
Measurement of basal forebrain atrophy in Alzheimer's disease using MRIStefan J Teipel, Wilhelm H Flatz, Helmut Heinsen, et al.
Neurobiology of Aging|February 24, 2020
Association of brain network dynamics with plasma biomarkers in subjective memory complainersPatrizia A Chiesa, Marion Houot, Andrea Vergallo, et al.
Psychiatry Research|August 2, 2008
Functional abnormalities of the visual processing system in subjects with mild cognitive impairment: an fMRI studyArun Lawrence Warren Bokde, Patricia Lopez-Bayo, Christine Born, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 31, 2009
Early risk assessment for Alzheimer's diseaseMaria C Carrillo, Andrew Blackwell, Harald Hampel, et al.
Journal of Alzheimer'S Disease : JAD|March 1, 2014
Fractional anisotropy changes in Alzheimer's disease depend on the underlying fiber tract architecture: a multiparametric DTI study using joint independent component analysisStefan J Teipel, Michel J Grothe, Massimo Filippi, et al.
Experimental Gerontology|June 23, 2009
Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI)Katharina Buerger, Giovanni Frisoni, Olga Uspenskaya, et al.
Expert Review of Molecular Diagnostics|April 21, 2022
α-synuclein as an emerging pathophysiological biomarker of Alzheimer's diseaseMaria Francesca Beatino, Ciro De Luca, Nicole Campese, et al.
Alzheimer'S Research & Therapy|December 7, 2023
The age-specific comorbidity burden of mild cognitive impairment: a US claims database studyGang Li, Nicola Toschi, Viswanath Devanarayan, et al.
Alzheimer'S Research & Therapy|June 23, 2023
Differential response to donepezil in MRI subtypes of mild cognitive impairmentPatricia Diaz-Galvan, Giulia Lorenzon, Rosaleena Mohanty, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersMarwan N Sabbagh, Daryl Jones, Jo Vandercappellen, et al.
Pageof 42

Showing results (211-220 of 411) with videos related to

Sort By:
Pageof 42
Brain : a Journal of Neurology|July 15, 2005
Measurement of basal forebrain atrophy in Alzheimer's disease using MRIStefan J Teipel, Wilhelm H Flatz, Helmut Heinsen, et al.
Neurobiology of Aging|February 24, 2020
Association of brain network dynamics with plasma biomarkers in subjective memory complainersPatrizia A Chiesa, Marion Houot, Andrea Vergallo, et al.
Psychiatry Research|August 2, 2008
Functional abnormalities of the visual processing system in subjects with mild cognitive impairment: an fMRI studyArun Lawrence Warren Bokde, Patricia Lopez-Bayo, Christine Born, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 31, 2009
Early risk assessment for Alzheimer's diseaseMaria C Carrillo, Andrew Blackwell, Harald Hampel, et al.
Journal of Alzheimer'S Disease : JAD|March 1, 2014
Fractional anisotropy changes in Alzheimer's disease depend on the underlying fiber tract architecture: a multiparametric DTI study using joint independent component analysisStefan J Teipel, Michel J Grothe, Massimo Filippi, et al.
Experimental Gerontology|June 23, 2009
Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI)Katharina Buerger, Giovanni Frisoni, Olga Uspenskaya, et al.
Expert Review of Molecular Diagnostics|April 21, 2022
α-synuclein as an emerging pathophysiological biomarker of Alzheimer's diseaseMaria Francesca Beatino, Ciro De Luca, Nicole Campese, et al.
Alzheimer'S Research & Therapy|December 7, 2023
The age-specific comorbidity burden of mild cognitive impairment: a US claims database studyGang Li, Nicola Toschi, Viswanath Devanarayan, et al.
Alzheimer'S Research & Therapy|June 23, 2023
Differential response to donepezil in MRI subtypes of mild cognitive impairmentPatricia Diaz-Galvan, Giulia Lorenzon, Rosaleena Mohanty, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersMarwan N Sabbagh, Daryl Jones, Jo Vandercappellen, et al.
Pageof 42